The latest data point for ACN's operating expenses, as of Q2'26, shows SG&A expenses at $2.97B USD, with R&D expenses remaining at no data, resulting in total operating expenses of $2.97B USD for the quarter. This reflects a slight decline from the previous quarter's $3.02B USD total. Over the period from Q3'23 to Q2'26, SG&A expenses—the sole contributor to operating costs—exhibited a mild downward trend initially, declining from $2.82B USD to a low of $2.72B USD in Q2'24, before steadily rising to $2.97B USD by Q2'26, indicating overall growth of approximately 5% across the timeframe. R&D expenses consistently showed no data throughout, suggesting this category is either negligible or not reported separately. The stacked bar chart highlights SG&A's dominance in operating expenses, with no significant volatility but a clear recovery and upward trajectory post-Q2'24, potentially signaling improved operational efficiency or scaling activities.